Lv2
180 积分 2025-09-09 加入
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management
1个月前
已完结
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
1个月前
已完结
Autoimmune neuro-ophthalmic disorders: pathophysiologic mechanisms and targeted biologic therapies
1个月前
已完结
The evolution and current status of anti-B-cell therapies in autoimmune neurologic diseases
1个月前
已关闭
Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis
1个月前
已完结
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom
1个月前
已完结
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center
2个月前
已完结
Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
2个月前
已关闭
Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series
2个月前
已完结
Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
2个月前
已关闭
皖公网安备34019202002308
